ArticleGesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany))2023
[Spreading Dynamics of the Alpha and Beta Virus Variants of SARS-CoV-2 at the Beginning of Their Appearance in the City of Cologne in January and February 2021].
Article in Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
background and aim of the studyConstantly changing virus variants of the novel coronavirus SARS-CoV-2 pose major challenges to the healthcare system. The aim of the present study was to analyse major outbreaks of the alpha and beta variants in Cologne in order to enable effective and rapid response to new virus variants in future pandemics as well as to derive targeted measures to combat the pandemic.
methodsIn the observation period from January 22 to February 23, 2021, all individuals testing positive for SARS-CoV-2 and their contact persons who were reported to the Cologne Public Health Department were interviewed by employees of the Public Health Department over the telephone. On the one hand, these data formed the basis for the epidemiological and descriptive comparison of the alpha and beta variants to the previously dominant wild type. On the other hand, they were also the basis for the graphical processing of clusters formed by the two virus variants in the form of so-called timelines. For the present work, all clusters with ≥10 individuals were taken into account for the period under consideration.
resultsOf the 3780 individuals that tested positive for SARS-CoV-2 in Cologne during the observation period, 818 cases were due to the virus variants alpha and beta. The alpha versus the beta variant spread quickly in Cologne despite strict non-pharmaceutical interventions. As part of the cluster analysis, five major outbreak were identified in Cologne during the observation period. The alpha variant clusters included two daycare centers and one monastery, while the beta variant clusters included a communal accommodation for refugees and an old people's and nursing home. With the help of cluster analysis, the core role of the spread of the virus variants examined was shown, especially in the context of the home setting. In addition, a high proportion of cases of unknown infection site/contact was found for the wild type and alpha variant.
conclusionCluster analyses are an extremely useful tool in the determination of infection sites/contacts and transmission paths as well as in determining existing protective measures and hygiene concepts. Since clusters are to be regarded as the most unfavorable spread scenario, cluster analyses provide important suggestions for modifying further action for both this, as well as for future pandemics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.